Showing results (2341-2350 of 4,276) with videos related to
Sort By:
Pageof 428
Cancer Discovery|January 20, 2026
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D InhibitorLing Xie, Chunwei Xu, Han Si, et al.Cancer Discovery|May 10, 2013
Discovering what makes STAT signaling TYK in T-ALLLorena Fontan, Ari MelnickCancer Discovery|April 13, 2013
A model for primary melanoma of the CNS implicates NRASChristie A Ciarlo, Leonard I ZonCancer Discovery|April 16, 2013
Illuminating cancer systems with genetically engineered mouse models and coupled luciferase reporters in vivoBrandon Kocher, David Piwnica-WormsCancer Discovery|February 19, 2013
Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectivesMaria Vittoria Dieci, Monica Arnedos, Fabrice Andre, et al.Cancer Discovery|February 23, 2013
Targeting MYCN in neuroblastoma by BET bromodomain inhibitionAlexandre Puissant, Stacey M Frumm, Gabriela Alexe, et al.Cancer Discovery|July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)Manav Korpal, Joshua M Korn, Xueliang Gao, et al.Cancer Discovery|July 13, 2013
ERK pathway inhibitors: how low should we go?Moriah H Nissan, Neal Rosen, David B SolitCancer Discovery|July 13, 2013
Scanning for clues to better use selective estrogen receptor modulatorsMitchell J Machiela, Stephen J ChanockCancer Discovery|July 13, 2013
New risk factors for testicular cancerPageof 428